Puma Biotechnology, Inc. (PBYI)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Dec 27, 2024

$3.08

P/E Ratio

6.49

Market Cap

$151.19M

Loading...
Description

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Metrics

Overview

  • HQLos Angeles, CA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerPBYI
  • Price$3.08-2.22%

Trading Information

  • Market cap$151.19M
  • Float71.01%
  • Average Daily Volume (1m)521,020
  • Average Daily Volume (3m)435,877
  • EPS$0.48

Company

  • Revenue$243.57M
  • Rev growth (1yr)43.53%
  • Net income$20.32M
  • Gross margin63.87%
  • EBITDA margin30.99%
  • EBITDA$24.96M
  • EV$115.04M
  • EV/Revenue0.47
  • P/E6.49
  • P/S0.62
  • P/B2.13
Documents